|
|
Blood, 1 September 2006, Vol. 108, No. 5, pp. 1627-1634.
Prepublished online as a Blood First Edition Paper on May 18, 2006; DOI 10.1182/blood-2006-11-010389.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Suppression of T-cell functions by human granulocyte arginase
Markus Munder,
Henriette Schneider,
Claudia Luckner,
Thomas Giese,
Claus-Dieter Langhans,
Jose M. Fuentes,
Pascale Kropf,
Ingrid Mueller,
Armin Kolb,
Manuel Modolell, and
Anthony D. Ho
From the Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Germany; Institute of Immunology, University of Heidelberg, Germany; Children's Hospital, University of Heidelberg, Germany; Departamento de Bioquímica y Biología Molecular, E.U. Enfermería y T.O., Universidad de Extremadura, Cáceres, Spain; Department of Immunology, Faculty of Medicine, Imperial College London, United Kingdom; Department of Surgery, University Hospital Heidelberg, Germany; and Department of Cellular Immunology, Max-Planck-Institute for Immunobiology, Freiburg, Germany.
Chronic inflammation is accompanied by impaired T-cell immunity. In the mouse, myeloid cell-associated arginase accounts for the suppression of immune reactivity in various models of tumor growth and chronic infections. Here we show that arginase I is liberated from human granulocytes, and very high activities accumulate extracellularly during purulent inflammatory reactions. Human granulocyte arginase induces a profound suppression of T-cell proliferation and cytokine synthesis. This T-cell phenotype is due to arginase-mediated depletion of arginine in the T-cell environment, which leads to CD3 chain down-regulation but does not alter T-cell viability. Our study therefore demonstrates that human granulocytes possess a previously unanticipated immunosuppressive effector function. Human granulocyte arginase is a promising pharmacologic target to reverse unwanted immunosuppression.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. P. Cobbold, E. Adams, C. A. Farquhar, K. F. Nolan, D. Howie, K. O. Lui, P. J. Fairchild, A. L. Mellor, D. Ron, and H. Waldmann
Infectious tolerance via the consumption of essential amino acids and mTOR signaling
PNAS,
July 21, 2009;
106(29):
12055 - 12060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Liu, C. Zhang, A. Sun, Y. Zheng, L. Wang, and X. Cao
Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
J. Immunol.,
May 15, 2009;
182(10):
6207 - 6216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mandruzzato, S. Solito, E. Falisi, S. Francescato, V. Chiarion-Sileni, S. Mocellin, A. Zanon, C. R. Rossi, D. Nitti, V. Bronte, et al.
IL4R{alpha}+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
J. Immunol.,
May 15, 2009;
182(10):
6562 - 6568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oberlies, C. Watzl, T. Giese, C. Luckner, P. Kropf, I. Muller, A. D. Ho, and M. Munder
Regulation of NK Cell Function by Human Granulocyte Arginase
J. Immunol.,
May 1, 2009;
182(9):
5259 - 5267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Mylonas, M. G. Nair, L. Prieto-Lafuente, D. Paape, and J. E. Allen
Alternatively Activated Macrophages Elicited by Helminth Infection Can Be Reprogrammed to Enable Microbial Killing
J. Immunol.,
March 1, 2009;
182(5):
3084 - 3094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-S. Choi, I. C. Martinez-Falero, C. Corset, M. Munder, M. Modolell, I. Muller, and P. Kropf
Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages
J. Leukoc. Biol.,
February 1, 2009;
85(2):
268 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ckless, A. Lampert, J. Reiss, D. Kasahara, M. E. Poynter, C. G. Irvin, L. K. A. Lundblad, R. Norton, A. van der Vliet, and Y. M. W. Janssen-Heininger
Inhibition of Arginase Activity Enhances Inflammation in Mice with Allergic Airway Disease, in Association with Increases in Protein S-Nitrosylation and Tyrosine Nitration
J. Immunol.,
September 15, 2008;
181(6):
4255 - 4264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. van Cruijsen, A. A.M. van der Veldt, L. Vroling, D. Oosterhoff, H. J. Broxterman, R. J. Scheper, G. Giaccone, J. B.A.G. Haanen, A. J.M. van den Eertwegh, E. Boven, et al.
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
Clin. Cancer Res.,
September 15, 2008;
14(18):
5884 - 5892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kitowska, D. Zakrzewicz, M. Konigshoff, I. Chrobak, F. Grimminger, W. Seeger, P. Bulau, and O. Eickelberg
Functional role and species-specific contribution of arginases in pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol,
January 1, 2008;
294(1):
L34 - L45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Morris Jr.
Arginine Metabolism: Boundaries of Our Knowledge
J. Nutr.,
June 1, 2007;
137(6):
1602S - 1609S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Popovic, H. J. Zeh III, and J. B. Ochoa
Arginine and Immunity
J. Nutr.,
June 1, 2007;
137(6):
1681S - 1686S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Jacobsen, K. Theilgaard-Monch, E. I. Christensen, and N. Borregaard
Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils
Blood,
April 1, 2007;
109(7):
3084 - 3087.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|